Paola Gazzaniga

Pubblicazioni

Titolo Pubblicato in Anno
Early Detection of Disease Progression in Metastatic Cancers: Could CTCs Improve RECIST Criteria? BIOMEDICINES 2024
Circulating Cancer-Associated Macrophage-like Cells as a Blood-Based Biomarker of Response to Immune Checkpoint Inhibitors INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2024
VI‐RADS followed by Photodynamic Transurethral Resection of Non‐Muscle‐Invasive Bladder Cancer vs White‐Light Conventional and Second‐resection: the ‘CUT‐less’ Randomised Trial Protocol BJU INTERNATIONAL 2024
Blood Extracellular Vesicles beyond Circulating Tumour Cells: A Valuable Risk Stratification Biomarker in High-Risk Non-Muscle-Invasive Bladder Cancer Patients BIOMEDICINES 2024
Signet ring cell carcinoma of the urinary bladder presenting with carcinocythemia and skeletal metastasis: A case report TUMOR DISCOVERY 2024
Exploring the utility of a NGS multigene panel to predict BCG response in patients with non-muscle invasive bladder cancer ONCOLOGY RESEARCH 2024
Genomic landscape and survival analysis of ctDNA “neo-RAS wild-type” patients with originally RAS mutant metastatic colorectal cancer FRONTIERS IN ONCOLOGY 2023
Prognostic Role of Circulating Tumor Cell Trajectories in Metastatic Colorectal Cancer CELLS 2023
Is cancer an intelligent species? CANCER METASTASIS REVIEWS 2023
An organoid model of colorectal circulating tumor cells with stem cell features, hybrid EMT state and distinctive therapy response profile JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH 2022
RAS mutation conversion in bevacizumab-treated metastatic colorectal cancer patients: a liquid biopsy based study CANCERS 2022
Modeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design Simulation THE ONCOLOGIST 2022
Response to immunotherapy in KRAS G12C mutated NSCLC: a single-centre retrospective observational study ONCOTARGET 2022
An Orthotopic Patient-Derived Xenograft (PDX) Model Allows the Analysis of Metastasis-Associated Features in Colorectal Cancer FRONTIERS IN ONCOLOGY 2022
In vitro cultures of circulating tumor cells: a potential tool to unravel drug sensitivity CANCER DRUG RESISTANCE 2022
A Fast and Furious Liquid Biopsy Assay to Monitor Targeted Therapy Resistance inglese 2022
127P {RAS}, {RAF} and {NF}1 oncogenic mutations in {KRAS}-mutated lung adenocarcinoma ANNALS OF ONCOLOGY 2022
True conversions from RAS mutant to RAS wild-type in circulating tumor DNA from metastatic colorectal cancer patients as assessed by methylation and mutational signature CANCER LETTERS 2021
Sequential isolation and characterization of single CTCs and large CTC clusters in metastatic colorectal cancer patients CANCERS 2021
Comparison of two blood-based genotyping tests to investigate the KRAS G12C mutation in patients with non-small-cell lung cancer at failure of first-line treatments DIAGNOSTICS 2021

ERC

  • LS4_12

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

liquid biopsy of cancer, circulating tumor DNA, circulating tumor cells

Keywords

liquid biopsy

Progetti di Ricerca

Laboratori di ricerca

BIOPSIA LIQUIDA LAB 01

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma